Giving Your Drug Product Manufacturing a Fresh, More Productive Start

How we help set - and keep - your success in motion

Making the Switch to Emergent Bioservices

Getting it right from the start is a critical factor when developing your next drug product and more so when selecting your next CDMO. Before choosing an external manufacturing partner, consider these benchmark characteristics:

Capacity & Scale

A partner who can scale up and is primarily configured to manufacture both clinical and commercial supply.

Quality

A partner who prioritizes the processes, culture, and technologies to ensure consistent quality & commercial compliance. 

Technical Expertise

Dedicated and skilled team with decades of experience specializing in complex development and cGMP manufacturing programs.

Timeline

A partner who has the capacity, capability, and track record to meet aggressive timelines.

Geographic

A partner who is conveniently located to API suppliers, clinical trial locations, primary commercial markets, an experienced workforce, etc.

Presentation

A partner who can accommodate your preferred presentation (vials and syringes) and liquid &  lyophilization

Aligning to Your Manufacturing Needs at Every Stage

If any of these characteristics don’t sound familiar when working with your current CDMO, a switch is easier than you might think. While we’re able to take on your program at any point in your drug development pathway, our clients typically have switched to us when:

They’ve just completed Phase I

They’ve used one CDMO for small-scale trials but need a partner with more robust capabilities for Phase II and beyond.

They’re about to start Phase III

They have to be able to run Phase III registration lots with their intended commercial supplier.

They have an approved product

Their product is already on the market and they need a commercial tech transfer to provide primary or additional supply, secondary supply, supply in a particular geography, etc.

Let's Do Your Impossible

As your team unites to address your innovative therapeutic or vaccine, our team would welcome the opportunity to contribute our special capabilities to your efforts. Wherever your instincts and inspirations lead, we possess the experience, knowledge, and capabilities to support your program. 

We can get started together with an initial assessment, viability analysis, or virtual facility tour or onsite visit. But often the best way to kickstart the process is with a conversation so we can get a better sense of your specific goals, unique needs, and key development drivers. 

The sooner we connect, the sooner we can help put your product in the hands of patients who can benefit so greatly from it. So let’s start today.